Journal Report

CLINICAL CANCER RESEARCH

Download PDF
Journal Information
Journal Title
CLINICAL CANCER RESEARCH
Publisher
AMER ASSOC CANCER RESEARCH
ISSN
1078-0432
E-ISSN
1557-3265
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
An Act of DeFianCe: Targeting DKK1 in Metastatic Colorectal Cancer
Thejal Srikumar, Raghav Sundar
2026-10-30
DOI: 10.1158/1078-0432.ccr-26-2653
Type II ROS1 Inhibition Overcomes Type I Inhibitor Resistance in ROS1 Fusion–Positive Lung Cancers: A Phase II Trial of Cabozantinib
Jaime Rubio-Perez, Matteo Repetto, Ling Feng Ye et al.
2026-10-30 Pages OF1-OF7
DOI: 10.1158/1078-0432.ccr-26-2860
Transcriptional Signatures Indicating RB Function Correlate with Response to CDK4/6 Inhibition in Endometrial Cancer
Zelei Yang, Upendra Raj Bhattarai, Martin K. Hayes et al.
2026-10-30 Pages OF1-OF12
DOI: 10.1158/1078-0432.ccr-26-0071
Progress in Clinical Care and Research for Li–Fraumeni Syndrome: Perspectives from the Seventh Li–Fraumeni Syndrome Association REACH Symposium
Suzanne P. MacFarland, Nabamita Boruah, Megan N. Frone et al.
2026-10-30 Pages OF1-OF8
DOI: 10.1158/1078-0432.ccr-26-2137
Long-term Outcomes of Modified-Intensity Lenalidomide, Bortezomib, and Dexamethasone (RVD-Lite) in Transplant-Ineligible Multiple Myeloma: Final Report of a Phase II Trial
Joshua N. Gustine, Elizabeth K. O’Donnell, Jacob P. Laubach et al.
2026-10-30 Pages OF1-OF7
DOI: 10.1158/1078-0432.ccr-26-0794
When the Tumor Disappears, Must the Larynx Follow?
Achraf A. Shamseddine, Nadeem Riaz
2026-10-27 Pages OF1-OF3
DOI: 10.1158/1078-0432.ccr-26-2916
Topoisomerase-Based CDH17 Antibody–Drug Conjugates Overcome P-gp Resistance but Undergo Target-Mediated Clearance in Colorectal Cancer
Neil A. O’Brien, Jun Zhang, Ke Wei Gong et al.
2026-10-27 Pages OF1-OF14
DOI: 10.1158/1078-0432.ccr-26-2010
Drug-Specific Resistance Mechanisms to RET Inhibitors in <i>RET</i> Fusion–Positive NSCLC
Ximeng Liu, Alvaro G. Paula, Monique B. Nilsson et al.
2026-10-27 Pages OF1-OF12
DOI: 10.1158/1078-0432.ccr-26-2630
Endotrophin Is a Circulating Fibroinflammatory Biomarker Associated with Treatment Response in Human Metastatic ER+ Breast Cancer
Bethania Santos, Dawei Bu, Megan Virostek et al.
2026-10-27 Pages OF1-OF10
DOI: 10.1158/1078-0432.ccr-25-3775
Dual VEGF and PD-(L)1 Blockade: Facts and Hopes
Magali Terme, Morgane Bourhis, Arthur Daban et al.
2026-10-26
DOI: 10.1158/1078-0432.ccr-25-3556
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 1, 2026 06:17